Emisphere Technologies Inc (EMIS1)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
6
240 CEDAR KNOLLS RD., SUITE 200, CEDAR KNOLLS, NJ 07927
973-532-8000

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 480.497 Million Shares Outstanding84.15 Million Avg 30-day Volume 82.452 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.04
Price to Revenue26.4883 Debt to Equity-0.4386 EBITDA9.478 Million
Price to Book Value0.0 Operating Margin-595.5939 Enterprise Value91.104 Million
Current Ratio0.784 EPS Growth0.375 Quick Ratio0.742
1 Yr BETA 1.0895 52-week High/Low 0.0 / Profit Margin-205.7471
Operating Cash Flow Growth-284.2176 Altman Z-Score-144.8801 Free Cash Flow to Firm -12.772 Million
View SEC Filings from EMIS1 instead.

View recent insider trading info

Funds Holding EMIS1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EMIS1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RACHESKY MARK H MD

MHR CAPITAL PARTNERS MASTER ACCOUNT LP

MHR ADVISORS LLC

MHR INSTITUTIONAL PARTNERS II LP

MHR INSTITUTIONAL PARTNERS IIA LP

MHR INSTITUTIONAL ADVISORS II LLC

MHRC LLC

MHRC II LLC

MHR FUND MANAGEMENT LLC

MHR HOLDINGS LLC

  • Director
  • 10% Owner
0 2017-06-30 0

ROTHWELL TIMOTHY G

  • Director
0 2017-05-18 0

RACHESKY MARK H MD

  • Director
  • 10% Owner
0 2017-05-18 0

WEISER MICHAEL

  • Director
0 2017-05-18 0

MCINERNEY TIMOTHY

  • Director
0 2017-05-18 0

HARKEY JOHN D JR

  • Director
0 2017-05-18 0

PLOTSKER JACOB M

  • Director
0 2017-05-18 0

RUBINO ALAN L CEO

  • Officer
0 2017-01-24 0

GALLANTAR ALAN V INTERIM CFO

  • Officer
0 2016-06-22 0

GARONE MICHAEL CFO

  • Officer
0 2016-01-14 0

RACHESKY MARK H MD

MHR CAPITAL PARTNERS MASTER ACCOUNT LP

MHR ADVISORS LLC

MHR INSTITUTIONAL PARTNERS II LP

MHR INSTITUTIONAL PARTNERS IIA LP

MHR INSTITUTIONAL ADVISORS II LLC

MHR FUND MANAGEMENT LLC

MHR HOLDINGS LLC

  • Director
  • 10% Owner
0 2012-12-31 0

MHRC LLC

  • 10% Owner
7,073,179 2012-12-31 0

MHRC II LLC

  • 10% Owner
11,405,186 2012-12-31 0

RILEY GARY SEE REMARKS

  • Officer
0 2012-05-31 0

RACHESKY MARK H MD

MHR CAPITAL PARTNERS MASTER ACCOUNT LP

MHR ADVISORS LLC

MHR INSTITUTIONAL PARTNERS II LP

MHR INSTITUTIONAL PARTNERS IIA LP

MHR INSTITUTIONAL ADVISORS II LLC

MHR FUND MANAGEMENT LLC

  • Director
  • 10% Owner
0 2011-12-31 0

MHR INSTITUTIONAL PARTNERS II LP

MHR FUND MANAGEMENT LLC

MHR INSTITUTIONAL ADVISORS II LLC

RACHESKY MARK H MD

  • Director
  • 10% Owner
2,412,718 2010-08-26 0

RACHESKY MARK H MD

MHR CAPITAL PARTNERS MASTER ACCOUNT LP

MHR ADVISORS LLC

MHR INSTITUTIONAL PARTNERS IIA LP

MHR INSTITUTIONAL ADVISORS II LLC

MHR FUND MANAGEMENT LLC

  • Director
  • 10% Owner
0 2010-06-30 0

NOVINSKI MICHAEL V CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2010-03-10 0

MOCH KENNETH I

  • Director
0 2009-05-15 0

BERGER FRANKLIN M

  • Director
0 2009-05-15 0

CARTER STEPHEN K

  • Director
11,107 2008-08-13 0

PACK HOWARD M

  • Director
101,470 2008-08-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments